Missing a competitor? Contribute!
Gilead is seen as one of Actelion's biggest rivals. Gilead was founded in 1987 in Foster City, California. Like Actelion, Gilead also operates in the Pharmaceuticals sector. Gilead generates $23.2B more revenue than Actelion.
Genentech is one of Actelion's top competitors. Genentech was founded in 1976, and its headquarters is in South San Francisco, California. Like Actelion, Genentech also operates in the Pharmaceuticals space. Genentech has 11,079 more employees than Actelion.
Amgen is one of Actelion's top rivals. Amgen was founded in 1980, and is headquartered in Thousand Oaks, California. Like Actelion, Amgen also works within the Pharmaceuticals sector. Amgen generates $22.8B more revenue vs. Actelion.
Weigh-in!Help the Owler community know more
Growth Score - 1/1
Is 2,421 a good estimate for Actelion's Employee count?
Trending News for Actelion and Actelion's Competitors
These are all the companies that Actelion has acquired. Actelion's latest acquisition was Axovan AG in Sep 2003.
Actelion Funding History
No recent funding data found related to Actelion
No recent investments found related to Actelion
These are all the companies that Actelion has invested in. Actelion's latest investment was Axovan AG in Sep 2003.
August 29, 2020MarketScreener
TRITON Phase 3b Study Results Presented at the European Society of Cardiology Congress
(marketscreener.com) While the primary endpoint was not met, exploratory analysis suggests a signal o... See more » June 18, 2020Zolmax News
Actelion (OTCMKTS:ALIOF) Getting Very Negative Media Coverage, Report Finds
News stories about Actelion (OTCMKTS:ALIOF) have been trending very negative on Thursday, according t... See more » May 18, 2020Zolmax News
Actelion (OTCMKTS:ALIOF) vs. Aphria (OTCMKTS:APHA)
Actelion (OTCMKTS:ALIOF) and Aphria (NYSE:APHA) are both medical companies, but which is the better b... See more » May 1, 2020The Pharma Letter
BRIEF-Actelion's Opsumit improves RV function in PAH trial
Switzerland-based Actelion has presented new trial results on the effects of Opsumit (macitentan) on.... See more » January 26, 2020BioPortfolio
Actelion Ltd Strategy SWOT and Corporate Finance Report Published by Marketline Prices from USD $149
Actelion Ltd Strategy SWOT and Corporate Finance ReportSummaryActelion Ltd Strategy SWOT and Corporat... See more » November 13, 2019The Pharma Letter
Actelion pulls supplemental indication applications for Opsumit
Actelion Pharmaceuticals has decided to voluntarily withdraw the European and other health authority.... See more » July 26, 2019FinanzNachrichten
Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal
NEW BRUNSWICK (dpa-AFX) - Idorsia Ltd said that the Janssen Pharmaceutical Companies of Johnson & Joh... See more »
Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs. Actelion was founded in 1997. Actelion's headquarters is located in Allschwil, Basel-Country, CH 4123. Actelion's latest acquisition was Axova...
Frequently Asked Questions about Actelion
When was Actelion founded?Actelion was founded in 1997
How much revenue does Actelion generate?Actelion generates $2.4B in revenue
How much funding does Actelion have?Actelion has historically raised $0 in funding
Where is Actelion's headquarters?Actelion's headquarters is in Allschwil Basel-Country, CH
How many employees does Actelion have?Actelion has 2,421 employees
What sector does Actelion operate in?Actelion is in Pharmaceuticals
Who are Actelion's competitors?Actelion's top competitors are Gilead, Genentech, Amgen